Suchergebnisse - "Fendler, Annika"

PubPharm (65)

1

PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors

enthalten in: BMC urology | 2024

von Plage, H. | Furlano, K. | Hofbauer, S. | +29

2

PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors

enthalten in: BMC urology | 2024

von Plage, H. | Furlano, K. | Hofbauer, S. | +29

3

Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder

enthalten in: International urology and nephrology | 2024

von Kaczmarek, K. | Plage, H. | Furlano, K. | +29

4

Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors

enthalten in: PloS one | 2024

von Myszczyszyn, A. | Popp, O. | Kunz, S. | +6

5

Zielgerichtete Therapieoptionen in der Uroonkologie

enthalten in: Best Practice Onkologie | 2023

von Franz, A. | Plage, H. | Fendler, A. | +2

6

Zielgerichtete Therapieoptionen in der Uroonkologie

enthalten in: Best practice Onkologie | 2023

von Franz, A. | Plage, H. | Fendler, A. | +2

7

Precision oncology options in urological cancers

enthalten in: Urologie (Heidelberg, Germany) | 2023

von Franz, A. | Plage, H. | Fendler, A. | +2

8

Zielgerichtete Therapieoptionen in der Uroonkologie

enthalten in: Die Urologie | 2023

von Franz, A. | Plage, H. | Fendler, A. | +2

9

Zielgerichtete Therapieoptionen in der Uroonkologie

enthalten in: Die Urologie | 2023

von Franz, A. | Plage, H. | Fendler, A. | +2

10

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

enthalten in: Cancer cell | 2023

von Wu, M. | Shepherd, S. | Fendler, A. | +64

1
2
3
4
5
6
7
Nächster »
[7]